Current NMCC Clinical Trials

Breast
NSABP B-49: Comparing the combination of Docetaxel plus Cyclophosphamide to Anthracycline-based chemotherapy regimens for women with node-positive or high-risk node-negative, HER2-negative Breast Cancer

Amgen 20110148: Randomized, single blind study to estimate the effect of patient education on reported bone pain in Breast Cancer patients receiving chemotherapy and Pegfilgrastim

Colorectal
I4T-MC-JVBB:  Irinotecan, Folinic Acid, And FOLFIRI plus Ramucirumab or Placebo in Patients with Metastatic Colorectal Carcinoma Progressive during or Following First-Line Combination Therapy with Bevacizumab, Oxaliplatin

Lung
Boehringer Ingelheim 1200.45: Open label expande3d access program of Afatinib for patients with locally advanced or metastatic Non-Small Cell Lung Cancer harboring EGFR mutations
Supportive Care

Multiple Myeloma
Lilly Multiple Myeloma: A Double-Blind, Placebo-Controlled Phase 2/3 Study of Tabalumab in Combination with Bortezomib and Dexamethasone in Patients with Previously Treated Multiple Myeloma

Prostate
RTOG  0534: A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients with A Rising PSA After Radical Prostatectomy

P10-3 PROCEED Registry: A Registry of Sipuleucel-T Therapy in Men with Advanced Prostate Cancer

Supportive Care
Tesaro Supportive Care: A Phase 3, Double-Blind, Active-Controlled Study of the Efficacy of Rolipitant for the Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemo

WEX TTX-CINP-201: Double-blind, dose-finding, placebo controlled, multicenter study of Tetrodotoxin in the treatment of chemotherapy induced neuropathic pain